Lonza Appoints Former Journalist to Head External Communications
FOR IMMEDIATE RELEASE
February 26, 2014
Head Corporate Communications
Lonza Group Ltd
Tel +41 61 316 8798
Fax +41 61 316 9540
Basel, Switzerland, 26 February 2014 – Lonza, a leading global supplier to the pharmaceutical, biotech and specialty ingredients markets, announced today that Constance S. Ward has joined the company as the Head of External Communications.
In her new role, Ward will be a spokesperson for Lonza and take responsibility for coordinating media relations activities across the company and guide the overall positioning of Lonza through various external and internal communication channels.
Ward will be based in Basel and report to Dominik Werner, Head of Corporate Communications for Lonza. Werner will remain a spokesperson for the company and will continue to work with Swiss-based and German-speaking media, too.
With a Master’s degree in rhetorical theory from the University of Missouri in Columbia, MO (USA), Ward joined Lonza from her PR consultancy firm Thought Leader Zone. She has international communications and marketing experience working for multi-national companies that include Black & Veatch, GE Insurance Solutions, Zurich Financial Services and Roche Pharmaceuticals.
Previously, Ward worked as a journalist for U.S. and global publications, such as The Sunday Times and The Times of London; Financial Times’ East European Markets; East European Banker; UPI news wire service; Voice of America Radio; Radio Free Europe/Radio Liberty; The Kansas City Star, and various other business and mass media publications.
“With the addition of Connie to our team, we’re able to offer journalists and our business partners the benefit of her broad global experience in fields related to both of our market segments – Pharma&Biotech and Specialty Ingredients,” said Dominik Werner, Lonza’s Head of Corporate Communications.
Lonza is one of the world’s leading and most trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 10,000 employees worldwide. The company generated sales of about CHF 3.6 billion in 2013 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Lonza’s stock is publicly traded on the Swiss and the Singapore stock exchanges. Further information can be found at www.lonza.com.
What Members Are Saying…
“Right off the bat, SOCMA’s ChemStewards provides you with a template that shows you good practices that should be implemented across-the-board. And the dialogue with other members and SOCMA staff is very valuable. You would have to pay a lot of money to bring in that kind of expertise, but with SOCMA, it’s all a benefit of membership.”